MEDITECH TP-7 selank 5MG/3VIAL

MEDITECH TP-7 selank 5MG/3VIALTP7 Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a structural analog of the endogenous immunomodulatory peptide tuftsin (Thr Lys Pro Arg) with an added Pro Gly Pro sequence that enhances its stability and metabolic half life. Key characteristics include: Anxiolytic and Nootropic Effects: Selank is designed to provide anti anxiety effects without sedation, cognitive

• Anxiolytic and Nootropic Effects: Selank is designed to provide anti-anxiety effects without sedation, cognitive impairment, or addiction potential, making it distinct from traditional anxiolytics. 

  2
• Neurotransmitter Modulation: It enhances GABAergic signaling, increases serotonin metabolism, and modulates dopaminergic and noradrenergic tone, contributing to its nootropic effects. 

  2
• Immunomodulatory Activity: Selank influences immune function by modulating cytokine balance and enhancing the ability of phagocytes to engulf pathogens. 

  2
• Regulatory Approval: It received approval in Russia for the treatment of generalized anxiety disorder and as an adjunct therapy for neurasthenic conditions in 2009. 

  2

  
  Selank is marketed under the brand name Selanc® as an intranasal spray and is one of the few peptides with regulatory approval for anxiety disorders. 

  2